Future Nonmelanoma Skin Cancer Development Following Immune Checkpoint Inhibitor Therapy: A TriNetX Real-World Study

Published: 1 July 2026| Version 1 | DOI: 10.17632/3tyb3stj2x.1
Contributors:
Eli Kasheri, Colin Kincaid, Xiying Fan, Janellen Smith

Description

Supplemental Material for Future Nonmelanoma Skin Cancer Development Following Immune Checkpoint Inhibitor Therapy: A TriNetX Real-World Study for the Journal of the American Academy of Dermatology

Files

Categories

Dermatology

Licence